Grants per year
Personal profile
Education/Academic qualification
PhD, University of Lille
… → 2010
Fingerprint
Dive into the research topics where Catalina Lee Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The Identification and Rational Targeting of Immune Suppression in Malignant Chordoma
Wolinsky, J., Lee Chang, C., Lesniak, M. S. & Miska, J. M.
7/1/21 → 6/30/23
Project: Research project
-
Development of B-cell-based vaccine for Glioblastoma
Lee Chang, C., Balyasnikova, I. V., James, C. D. & Miska, J. M.
3/15/21 → 2/28/26
Project: Research project
-
B Cell Vaccine Promotes Anti-glioma Immunity Through Modulating CD8+ T cells
American Brain Tumor Association
6/1/22 → 8/31/22
Project: Research project
-
Immuno Core
University of California, San Francisco, National Cancer Institute
9/10/21 → 8/31/22
Project: Research project
-
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer
Cordero, A., Ramsey, M. D., Kanojia, D., Fares, J., Petrosyan, E., Schwartz, C. W., Burga, R., Zhang, P., Rashidi, A., Castro, B., Xiao, T., Lee-Chang, C., Miska, J., Balyasnikova, I. V., Ahmed, A. U. & Lesniak, M. S., Jan 4 2022, In: Proceedings of the National Academy of Sciences of the United States of America. 119, 1, e2112491119.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Erratum: HIF-1α Is a Metabolic Switch Between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma (Cell Reports (2019) 27(1) (226–237.e4), (S2211124719303456), (10.1016/j.celrep.2019.03.029))
Miska, J., Lee-Chang, C., Rashidi, A., Muroski, M. E., Chang, A. L., Lopez-Rosas, A., Zhang, P., Panek, W. K., Cordero, A., Han, Y., Ahmed, A. U., Chandel, N. S. & Lesniak, M. S., Jun 7 2022, In: Cell reports. 39, 10, 110934.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
New Approaches to Glioblastoma
Khasraw, M., Fujita, Y., Lee-Chang, C., Balyasnikova, I. V., Najem, H. & Heimberger, A. B., 2022, In: Annual review of medicine. 73, p. 279-292 14 p.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Next Steps for Immunotherapy in Glioblastoma
Cao, T. Q., Wainwright, D. A., Lee-Chang, C., Miska, J., Sonabend, A. M., Heimberger, A. B. & Lukas, R. V., Aug 2022, In: Cancers. 14, 16, 4023.Research output: Contribution to journal › Review article › peer-review
Open Access -
Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma (Nature Cancer, (2021), 2, 12, (1372-1386), 10.1038/s43018-021-00260-2)
Arrieta, V. A., Chen, A. X., Kane, J. R., Kang, S. J., Kassab, C., Dmello, C., Zhao, J., Burdett, K. B., Upadhyayula, P. S., Lee-Chang, C., Shilati, J., Jaishankar, D., Chen, L., Gould, A., Zhang, D., Yuan, J., Zhao, W., Ling, X., Burks, J. K., Laffleur, B., & 22 others, Mar 2022, In: Nature Cancer. 3, 3, p. 373 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access